A study has shown that some people have low levels of anti-coronary antibodies after completing both doses of the vaccine. It has been observed that the dose decreases within four months after taking the first dose. The study involved 614 fully vaccinated health workers in India. This study will help the government decide whether to give a booster dose or not.
Zee News reports that a decrease in antibodies does not mean that vaccinated people have a reduced ability to cope with the disease. This is because the memory cells in the body can still provide substantial protection. Sanghmitra Pati of the Regional Medical Research Center in the eastern city of Bhubaneswar told Reuters on Tuesday:
British researchers reported last month that the protection provided by two doses of Pfizer / Biotech and AstraZeneca vaccines began to weaken within six months. The current study includes the first two vaccines in the country, Covishield and Covacin.
Health officials say that although they are currently considering booster doses, it is a priority to fully vaccinate adults. More than 60% have received at least one dose and 19% have received the required two doses.